The outcome data in T1DM is very limited and more data is needed #SGLT2inhibitors #GLP1receptoragonist #SGLT2i #GLP1 #nsMRA #nonsteroidalmineralocorticoidreceptorantagonists #CVcomplications #DKD #cardioprotection #nephroprotection #combinationtherapy Martin Haluzks Post 2, 1- : Very interesting paper recently published in Diabetes Therapy by Elisabeth Buur Stougaard and colleagues
As a matter of fact, n in Table 6 went all the way from 1 (g(28,1) in Table 6) to 7 g(28,7) in Table 6, in comparison with the length (28) of the backbone of semaglutide, while the structural modeling (Modeller [44]) and and K d calculations (Prodigy [45, 46]) were performed completely only for g(28,1) (as in Table 6), as from Table 6, it is quite clear that the size of the computational task is too huge even for a high performance computing facility
Discontinuation can sometimes lead to weight regain if you do not follow the lifestyle changes
Semaglutide Dosage and Administration When administering your medication regimen of semaglutide and tirzepatide, it's essential to follow a precise protocol to ensure optimal effectiveness and safety